co.don chondrosphere, 10-70 sphäroide/cm^2 matrixassoziierte zellen zur implantation
co.don gmbh (1011513) - sphäroide aus humanen autologen matrixassoziierten chondrozyten - suspension zur implantation - teil 1 - transplantat humanen ursprungs; sphäroide aus humanen autologen matrixassoziierten chondrozyten (38505) zellen (biologische)
regeneresen nebennierenrinde injektionslösung
dyckerhoff pharma gmbh & co.kg - ribonucleinsäure-natriumsalz - injektionslösung - ribonucleinsäure-natriumsalz 6.3mg
kymriah
novartis europharm limited - tisagenlecleucel - precursor b-cell lymphoblastic leukemia-lymphoma; lymphoma, large b-cell, diffuse - andere antineoplastische mittel - kymriah is indicated for the treatment of:• paediatric and young adult patients up to and including 25 years of age with b cell acute lymphoblastic leukaemia (all) that is refractory, in relapse post transplant or in second or later relapse. • adult patients with relapsed or refractory diffuse large b cell lymphoma (dlbcl) after two or more lines of systemic therapy. • adult patients with relapsed or refractory follicular lymphoma (fl) after two or more lines of systemic therapy.
yescarta
kite pharma eu b.v. - axicabtagene ciloleucel - lymphoma, follicular; lymphoma, large b-cell, diffuse - antineoplastische mittel - yescarta is indicated for the treatment of adult patients with diffuse large b cell lymphoma (dlbcl) and high-grade b-cell lymphoma (hgbl) that relapses within 12 months from completion of, or is refractory to, first-line chemoimmunotherapy. yescarta is indicated for the treatment of adult patients with relapsed or refractory (r/r) dlbcl and primary mediastinal large b cell lymphoma (pmbcl), after two or more lines of systemic therapy. yescarta is indicated for the treatment of adult patients with r/r follicular lymphoma (fl) after three or more lines of systemic therapy.
spravato
janssen-cilag international nv - esketamine hydrochloride - depressive störung - andere antidepressiva - spravato, in kombination mit einem ssri oder snri, ist indiziert für erwachsene patienten mit therapieresistenten depressiven patienten, die nicht geantwortet haben, um mindestens zwei verschiedene behandlungen mit antidepressiva in der aktuellen moderaten bis schweren depressiven episode.
fentabucc akut 100 mikrogramm buccaltabletten
genericon pharma gesellschaft m.b.h. - fentanylcitrat -
fentabucc akut 200 mikrogramm buccaltabletten
genericon pharma gesellschaft m.b.h. - fentanylcitrat -
fentabucc akut 400 mikrogramm buccaltabletten
genericon pharma gesellschaft m.b.h. - fentanylcitrat -
fentabucc akut 600 mikrogramm buccaltabletten
genericon pharma gesellschaft m.b.h. - fentanylcitrat -
fentabucc akut 800 mikrogramm buccaltabletten
genericon pharma gesellschaft m.b.h. - fentanylcitrat -